Market Research Logo

Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)

Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)

Scope of the Report

The report titled “Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global ESRD market with detailed analysis of market size and growth, market share and economic impact of the industry. The report also provides market size of each of the segments of the market on the basis of the treatment opted by the patients along with the detailed overview of the home dialysis market. The report provides detailed market share analysis of the global dialysis market by players as well.

The report also includes the country analysis of the U.S. and Japan for ESRD market. It provides the analysis of ESRD patient volume along with the kidney transplant and dialysis market on the basis of the volume. The segments of the dialysis market are also analyzed in detail.

The report provides detailed regional analysis of North America, Europe, Meddle East and Africa (EMEA), Asia-Pacific and Latin America for the dialysis market. Regional analysis includes market size by volume along with the segments and clinic operators in each region.

Furthermore, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global ESRD market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global dialysis market is stiff and dominated by the big players like FMC. Further, key players of the dialysis market Baxter and Davita are also profiled with their financial information and respective business strategies.

Regional Coverage

North America
EMEA
Asia-Pacific
Latin America

Country Coverage

The U.S.
Japan

Company Coverage

Fresenius Medical Care
Baxter International
Davita Healthcare Partners

Executive Summary

End Stage renal disease (ESRD) occurs when the kidneys are no longer able to carry out their daily functions, requiring either dialysis or transplantation to sustain life. When properly functioning, kidneys act to filter the body of metabolic wastes, which are excreted as urine, and to maintain fluid balance. Chronic kidney failure, a decline in kidney function most often related to diabetes or hypertension, but resulting from other causes as well, including vascular disease, genetic disorders, and exposure to toxic levels of certain drugs. The best strategy for preventing ESRD is to detect chronic kidney failure at the earliest possible stage so that the decline in kidney function can be slowed through the use of medications and tight control of blood sugar and blood pressure levels.

The global ESRD market increased at a significant CAGR during the span of 5 years, i.e. 2010-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The upsurge in the market was due to the various reasons such as is diabetic nephropathy, genetic diseases, infection, drugs, traumatic injury, major surgery and etc. The market can be segmented on the basis of treatment as kidney transplant and dialysis. The global dialysis market can be segmented on the basis of products and services. On the basis of products, the market is segmented into hemodialysis and peritoneal dialysis while on the basis of services, the market is segmented into in-center dialysis and home dialysis.

The growth drivers for the market are: rise in diabetic and aging population, upsurge in per capita healthcare expenditure along with the emerging countries such as India, China and Brazil. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: disparities in the access to renal transplant therapy, less public awareness and negative societal effects.


1. Executive Summary
2. Introduction
2.1 Introduction to Kidney Diseases
2.2 End Stage Renal Disease (ESRD)
2.2.1 Causes of ESRD
2.2.2 Symptoms of ESRD
2.2.3 Diagnosis of ESRD
2.3 Treatment of ESRD
Table 1: Treatments of ESRD
2.3.1 Dialysis Treatment
Table 2: Types of Dialysis Treatments
2.3.2 Kidney Transplantation
3. Global ESRD Market Analysis
3.1 Global ESRD Market by Volume
Table 3: Global ESRD Market by Volume; 2010-2015 (Million)
Table 4: Global ESRD Market by Volume; 2016E-2020E (Million)
3.2 Global ESRD Prevalence Rate
Table 5: Global ESRD Prevalence Rate; 2010-2015E (p.m.p)
3.3 Global ESRD Market by Segments on the Basis of Treatment
Table 6: Global ESRD Market by Segments; 2015 (%)
4. Country Analysis: ESRD Market
4.1 The U.S. ESRD Market Analysis
4.1.1 The U.S. ESRD Market by Volume
Table 7: The U.S. ESRD Market by Volume; 2010-2015E (Thousand)
4.1.2 The U.S. ESRD Prevalence Rate
Table 8: The U.S. ESRD Prevalence Rate; 2010-2015E (p.m.p)
4.1.3 The U.S. ESRD Market by Causes of Disease
Table 9: The U.S. ESRD Market by Causes of Disease; 2013-2015E (%)
4.2 Japan ESRD Market Analysis
4.2.1 Japan ESRD Market by Volume
Table 10: Japan ESRD Market by Volume; 2010-2015E (Thousand)
4.2.2 Japan ESRD Market by Segments on the Basis of Treatment
Table 11: Japan ESRD Market by Segments; 2013-2015E (%)
5. Kidney Transplant Market Analysis
5.1 Global Kidney Transplant Market by Volume
Table 12: Global Kidney Transplant Market by Volume; 2010-2016E (Thousand)
5.2 Country Analysis of Kidney Transplant Market
5.2.1 The U.S. Kidney Transplant Market by Volume
Table 13: The U.S. Kidney Transplant Market by Volume; 2010-2015E (Thousand)
5.2.2 Japan Kidney Transplant Market by Volume
Table 14: Japan Kidney Transplant Market by Volume; 2010-2015E (Thousand)
6. Global Dialysis Market Analysis
6.1 Global Dialysis Market by Value
Table 15: Global Dialysis Market by Value; 2014-2020E (US$ Billion)
6.2 Global Dialysis Market by Volume
Table 16: Global Dialysis Market by Volume; 2010-2016E (Million)
6.3 Global Dialysis Market by Segments on the Basis of Products
Table 17: Global Dialysis Market by Segments on the Basis of Products; 2015 (%)
6.3.1 Global Hemodialysis Market by Volume
Table 18: Global Hemodialysis Market by Volume; 2010-2015 (Million)
6.3.2 Global Peritoneal Dialysis Market by Volume
Table 19: Global Peritoneal Dialysis Market by Volume; 2010-2015 (Thousand)
6.4 Global Dialysis Market by Segments on the Basis of Services
Table 20: Global Dialysis Market by Segments on the Basis of Services; 2014 (%)
6.5 Global Dialysis Prevalence Rate
Table 21: Global Dialysis Prevalence Rate; 2010-2015E (p.m.p)
6.6 Global Dialysis Market by Region
Table 22: Global Dialysis Market by Region; 2015 (%)
7. Regional Analysis: Dialysis Market
7.1 North America Dialysis Market Analysis
7.1.1 North America Dialysis Market by Volume
Table 23: North America Dialysis Market by Volume; 2010-2015 (Thousand)
7.1.2 The U.S. Dialysis Market Analysis
The U.S. Dialysis Market by Volume
Table 24: The U.S. Dialysis Market by Volume; 2010-2015E (Thousand)
The U.S. Hemodialysis Market by Volume
Table 25: The U.S. Hemodialysis Market by Volume; 2010-2015E (Thousand)
The U.S. Peritoneal Dialysis Market by Volume
Table 26: The U.S. Peritoneal Dialysis Market by Volume; 2010-2015E (Thousand)
7.2 EMEA Dialysis Market by Volume
Table 27: EMEA Dialysis Market by Volume; 2010-2015 (Thousand)
7.3 Asia-Pacific Dialysis Market Analysis
7.3.1 Asia-Pacific Dialysis Market by Volume
Table 28: Asia-Pacific Dialysis Market by Volume; 2010-2015 (Thousand)
7.3.2 Japan Dialysis Market Analysis
Japan Dialysis Market by Volume
Table 29: Japan Dialysis Market by Volume; 2010-2015E (Thousand)
Japan Hemodialysis Market by Volume
Table 30: Japan Hemodialysis Market by Volume; 2010-2015E (Thousand)
Japan Peritoneal Dialysis Market by Volume
Table 31: Japan Peritoneal Dialysis Market by Volume; 2010-2015E (Thousand)
7.4 Latin America Dialysis Market by Volume
Table 32: Latin America Dialysis Market by Volume; 2010-2015 (Thousand)
7.5 Regional Dialysis Market by Segments
Table 33: Regional Dialysis Market by Segments; 2015 (%)
7.6 Regional Dialysis Clinic Operators
Table 34: Regional Dialysis Clinic Operators; 2015 (%)
8. Home Dialysis Market Overview
8.1 Introduction to Home Dialysis
Table 35: Types of Home Dialysis
Table A: Pros and Cons of Various Types of Home Dialysis
8.2 Global Home Dialysis Market by Volume
Table 36: Global Home Dialysis Market by Volume; 2012-2015 (Thousand)
8.3 Regional Home Dialysis Market by Volume
Table 37: Regional Home Dialysis Market by Volume; 2012-2015 (Thousand)
8.4 The U.S. Home Dialysis Market by Volume
Table 38: The U.S. Home Dialysis Market by Volume; 201-2015 (Thousand)
8.5 Japan Home Hemodialysis Market by Volume
Table 39: Japan Home Hemodialysis Market by Volume; 2010-2015 (Thousand)
9. Market Dynamics
9.1 Growth Drivers
9.1.1 Increase in Diabetic Population
Table 40: Global Diabetic Population; 2011-2040E (Million)
9.1.2 Rising Aging Population
Table 41: Global Aging Population; 2010-2015E (Million)
9.1.3 Emerging Markets
Table 42: Global Emerging Markets; 2015 (%)
9.1.4 Upsurge in Healthcare per Capita Expenditure
Table 43: Global Healthcare per Capita Expenditure; 2010-2015E
9.2 Challenges
9.2.1 Disparities in the Access to Renal Transplant Therapy
9.2.2 Less Public Awareness
9.2.3 Negative Societal Effects
9.3 Market Trends
9.3.1 Health Trends Relating to ESRD
9.3.2 Higher Life Expectancy of ESRD Patients
9.3.3 Relationship between Mortality and ESRD Treatment
10. Competitive Landscape
10.1 Major Players in the Global Dialysis Market
Table 44: Global Dialysis Market by Players; 2015 (%)
10.1.1 Dialysis Key Products Group Players
Table B: Global Market Position of Major Players in Dialysis Key Product Groups; 2015
10.1.2 Global Dialysis Market Players by Segments
Table 45: Global Dialysis Market Players by Segments; 2015 (%)
10.2 Regional Dialysis Market Players
10.2.1 North America and Europe Dialysis Market Players
Table 46: North America and Europe Dialysis Market by Players; 2015 (%)
10.2.2 Asia-Pacific and Latin America Dialysis Market Players
Table 47: Asia-Pacific and Latin America Dialysis Market by Players; 2015 (%)
11. Company Profiling
11.1 Fresenius Medical Care AG & Co. KGaA
11.1.1 Business Overview
Table 48: FMC Business Segments
11.1.2 Financial Overview
Table 49: FMC Net Revenues; 2011-2015 (US$ Billion)
Table 50: FMC Net Revenue by Business Segments; 2015 (%)
Table 51: FMC Net Revenue by Regions; 2015 (%)
11.1.3 Business Strategy
11.2. Baxter International, Inc.
11.2.1 Business Overview
Table 52: Baxter International Business Segments
11.2.2 Financial Overview
Table 53: Baxter International Net Sales; 2011-2015 (US$ Billion)
Table 54: Baxter International Net Sale by Business Segment; 2015 (%)
Table 55: Baxter International Net Sales by Regions; 2015 (%)
11.2.3 Business Strategy
11.3 Davita Healthcare Partners Inc.
11.3.1 Business Overview
Table 56: Davita Healthcare Partners Business Segments
11.3.2 Financial Overview
Table 57: Davita Healthcare Partners Net Revenues; 2011-2015 (US$ Billion)
Table 58: Davita Healthcare Partners Net Revenue by Business Segment; 2015 (%)
11.3.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report